A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers (Q41453985)
Jump to navigation
Jump to search
scientific article published on 24 May 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers |
scientific article published on 24 May 2013 |
Statements
1 reference
A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers (English)
1 reference
Colin Stott
1 reference
Linda White
1 reference
Stephen Wright
1 reference
Darren Wilbraham
1 reference
Geoffrey Guy
1 reference
24 May 2013
1 reference
1 reference
2
1 reference
1
1 reference
236
1 reference
24 May 2013
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference